Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.

Authors

VYSKOČIL Jiří TUČEK Štěpán KISS Igor FĚDOROVÁ Lenka NEVRLKA Jiří ZDRAZILOVA-DUBSKA L

Year of publication 2019
Type Article in Periodical
Magazine / Source International Immunopharmacology
Citation
Web http://dx.doi.org/10.1016/j.intimp.2019.105728.Epub2019Jul6.
Doi http://dx.doi.org/10.1016/j.intimp.2019.105728.Epub2019Jul6.

You are running an old browser version. We recommend updating your browser to its latest version.

More info